Fulbright & Jaworski L.L.P.
Methods and compositions involving miRNA and miRNA inhibitor molecules
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
Asuragen Inc.
A A A A A A A C C C C A C C A C C C A C A C C A C C C A A C C C A C C A A A A C C C
A61K A61P A61P A61P A61N A61P A61P C12N C12N C12N C12N A61P C12N C12N A61K C12N C12N C12N A61P C12N A61K C12Q C12N A61K C12N C12N C12N A61P A61P C12N C12Q C12N A61P C12N C12N A61P A61K A61P A61P C12N C12Q C12Q
inventional inventional inventional inventional inventional inventional inventional additional additional additional inventional inventional additional additional inventional additional additional additional inventional inventional inventional inventional additional inventional additional additional additional inventional inventional additional additional additional inventional additional additional inventional inventional inventional inventional inventional additional inventional
Mike Eric Kevin Rich Lance David Angie Dmitriy
Byrom Devroe Kelnar Jarvis Ford Brown Cheng Ovcharenko